• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[大流行性流感疫苗。应如何设计?]

[Pandemic influenza vaccines. How should they be designed?].

作者信息

Löwer J

机构信息

Paul-Ehrlich-Institut, Paul-Ehrlich-Str. 51-59, 63225, Langen (Hessen), Deutschland.

出版信息

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1238-41. doi: 10.1007/s00103-010-1159-z.

DOI:10.1007/s00103-010-1159-z
PMID:21161473
Abstract

Pandemic influenza vaccines have to fulfill specific requirements. In contrast to seasonal influenza vaccines, they have to be effective even in an immunologically naïve population. In addition, they should be available in a relatively short period of time and should be produced at an unprecedented speed in huge amounts. For this reason, they need a specific design which has to be different from that of seasonal vaccines. With the given technological possibilities, antigen-sparing adjuvanted vaccines most closely fulfill the requirements of an ideal pandemic vaccine.

摘要

大流行性流感疫苗必须满足特定要求。与季节性流感疫苗不同,它们即使在免疫原初人群中也必须有效。此外,它们应在相对较短的时间内可用,并且应以前所未有的速度大量生产。因此,它们需要一种与季节性疫苗不同的特定设计。鉴于现有的技术可能性,抗原节约型佐剂疫苗最接近理想大流行疫苗的要求。

相似文献

1
[Pandemic influenza vaccines. How should they be designed?].[大流行性流感疫苗。应如何设计?]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1238-41. doi: 10.1007/s00103-010-1159-z.
2
[Concepts, effectiveness, and perspectives of pandemic and seasonal influenza vaccines].[大流行和季节性流感疫苗的概念、有效性及前景]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):76-86. doi: 10.1007/s00103-012-1590-4.
3
[Pandemic influenza vaccines. Concepts, European mock-up licenses, and acceptance criteria].[大流行性流感疫苗。概念、欧洲模拟许可及验收标准]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1242-9. doi: 10.1007/s00103-010-1161-5.
4
[The pandemic A/H1N1 in 2009 milder than regular seasonal influenza. Report from Uppsala County].[2009年甲型H1N1流感大流行比普通季节性流感更温和。来自乌普萨拉郡的报告]
Lakartidningen. 2012;109(23-24):1156-8.
5
[Pandemic preparedness planning. What did we learn from the influenza pandemic (H1N1) 2009?].[大流行防范规划。我们从2009年甲型H1N1流感大流行中学到了什么?]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Dec;53(12):1277-82. doi: 10.1007/s00103-010-1162-4.
6
The development of vaccine viruses against pandemic A(H1N1) influenza.针对大流行 A(H1N1) 流感的疫苗病毒的开发。
Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.
7
On the Centenary of the Spanish Flu: Being Prepared for the Next Pandemic.在西班牙流感百年之际:为下一场大流行做好准备。
Virol Sin. 2018 Dec;33(6):463-466. doi: 10.1007/s12250-018-0079-1. Epub 2018 Dec 20.
8
Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.大流行性流感 A(H1N1)的教训:基于研究的疫苗产业的观点。
Vaccine. 2011 Feb 1;29(6):1135-8. doi: 10.1016/j.vaccine.2010.11.042. Epub 2010 Nov 27.
9
Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.2010-2011 流感季节威斯康星州 2009 年甲型 H1N1 流感病毒单价疫苗和 2010-2011 年三价灭活流感疫苗的有效性。
J Infect Dis. 2013 Apr 15;207(8):1262-9. doi: 10.1093/infdis/jit020. Epub 2013 Jan 22.
10
CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.大流行性流感疫苗接种后的 CD4+ T 细胞免疫与季节性抗原发生交叉反应,并且在功能上与活性流感感染不同。
Eur J Immunol. 2012 Jul;42(7):1755-66. doi: 10.1002/eji.201242393.